Verici Dx plc
OTC: VRCDF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Sara jane Barrington
- Employees
- 19
- Headquarters
- Penarth, United Kingdom
- IPO year
- 2022
- Market cap
- $4.5M
- Website
- https://www.vericidx.com
Loading VRCDF…
Loading profile data…Frequently asked questions about VRCDF
What does Verici Dx plc (VRCDF) do?
Verici Dx plc is an immuno-diagnostics developer primarily dedicated to innovations within the kidney transplantation field. It creates both prognostic (predictive) and diagnostic (identifying current conditions) assays specifically designed for kidney transplant recipients. Its developmental pipeline currently features several key tests: Clarav...
Where does VRCDF trade?
Verici Dx plc (VRCDF) trades on the Other OTC.
What sector is VRCDF in?
Verici Dx plc (VRCDF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Verici Dx plc?
Sara jane Barrington is the chief executive officer of Verici Dx plc (VRCDF).
Where is Verici Dx plc headquartered?
Verici Dx plc is headquartered in United Kingdom.
Does VRCDF pay a dividend?
Verici Dx plc (VRCDF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VRCDF go public?
Verici Dx plc (VRCDF) completed its initial public offering in 2022.